Vitamin D decreases STAT phosphorylation and inflammatory cytokine output in T-LGL leukemia

References

• Zhang D, Loughran TP, Jr. Large granular lymphocytic leukemia: molecular pathogenesis, clinical manifestations, and treatment. Hematology Am Soc Hematol Educ Program 2012; 2012:652-9; PMID:23233648; https://doi.org/10.1182/asheducation-2012.1.652
   PubMedGoogle Scholar
• Lamy T, Loughran TP, Jr. How I treat LGL leukemia. Blood 2011; 117:2764-74; PMID:21190991; https://doi.org/10.1182/blood-2010-07-296962
   PubMed Web of Science ®Google Scholar
• Steinway SN, LeBlanc F, Loughran TP, Jr. The pathogenesis and treatment of large granular lymphocyte leukemia. Blood Rev 2014; 28:87-94; PMID:24679833; https://doi.org/10.1016/j.blre.2014.02.001
   PubMed Web of Science ®Google Scholar
• Abroun S, Saki N, Ahmadvand M, Asghari F, Salari F, Rahim F. STATs: An Old Story, Yet Mesmerizing. Cell J 2015; 17:395-411; PMID:26464811
   PubMed Web of Science ®Google Scholar
• Epling-Burnette PK, Liu JH, Catlett-Falcone R, Turkson J, Oshiro M, Kothapalli R, Li Y, Wang JM, Yang-Yen HF, Karras J, et al. Inhibition of STAT3 signaling leads to apoptosis of leukemic large granular lymphocytes and decreased Mcl-1 expression. J Clin Invest 2001; 107:351-62; PMID:11160159; https://doi.org/10.1172/JCI9940
   PubMed Web of Science ®Google Scholar
• Koskela HL, Eldfors S, Ellonen P, van Adrichem AJ, Kuusanmaki H, Andersson EI, Lagstrom S, Clemente MJ, Olson T, Jalkanen SE, et al. Somatic STAT3 mutations in large granular lymphocytic leukemia. N Engl J Med 2012; 366:1905-13; PMID:22591296; https://doi.org/10.1056/NEJMoa1114885
   PubMed Web of Science ®Google Scholar
• Jerez A, Clemente MJ, Makishima H, Koskela H, Leblanc F, Peng Ng K, Olson T, Przychodzen B, Afable M, Gomez-Segui I, et al. STAT3 mutations unify the pathogenesis of chronic lymphoproliferative disorders of NK cells and T-cell large granular lymphocyte leukemia. Blood 2012; 120:3048-57; PMID:22859607; https://doi.org/10.1182/blood-2012-06-435297
   PubMed Web of Science ®Google Scholar
• Rajala HL, Porkka K, Maciejewski JP, Loughran TP, Jr., Mustjoki S. Uncovering the pathogenesis of large granular lymphocytic leukemia-novel STAT3 and STAT5b mutations. Ann Med 2014; 46:114-22; PMID:24512550; https://doi.org/10.3109/07853890.2014.882105
   PubMed Web of Science ®Google Scholar
• Yang CY, Leung PS, Adamopoulos IE, Gershwin ME. The implication of vitamin D and autoimmunity: a comprehensive review. Clin Rev Allergy Immunol 2013; 45:217-26; PMID:23359064; https://doi.org/10.1007/s12016-013-8361-3
   PubMed Web of Science ®Google Scholar
• Adams JS, Hewison M. Unexpected actions of vitamin D: new perspectives on the regulation of innate and adaptive immunity. Nat Clin Pract Endocrinol Metab 2008; 4:80-90; PMID:18212810; https://doi.org/10.1038/ncpendmet0716
   PubMedGoogle Scholar
• Provvedini DM, Tsoukas CD, Deftos LJ, Manolagas SC. One,25-dihydroxyvitamin D3 receptors in human leukocytes. Science 1983; 221:1181-3; PMID:6310748; https://doi.org/10.1126/science.6310748
   PubMed Web of Science ®Google Scholar
• Manolagas SC, Werntz DA, Tsoukas CD, Provvedini DM, Vaughan JH. One,25-Dihydroxyvitamin D3 receptors in lymphocytes from patients with rheumatoid arthritis. J Lab Clin Med 1986; 108:596-600; PMID:3023512
   PubMed Web of Science ®Google Scholar
• Rigby WF, Stacy T, Fanger MW. Inhibition of T lymphocyte mitogenesis by 1,25-dihydroxyvitamin D3 (calcitriol). J Clin Invest 1984; 74:1451-5; PMID:6332829; https://doi.org/10.1172/JCI111557
   PubMed Web of Science ®Google Scholar
• Cantorna MT, Waddell A. The vitamin D receptor turns off chronically activated T cells. Ann N Y Acad Sci 2014; 1317:70-5; PMID:24673331; https://doi.org/10.1111/nyas.12408
   PubMed Web of Science ®Google Scholar
• Chen PT, Hsieh CC, Wu CT, Yen TC, Lin PY, Chen WC, Chen MF. 1alpha,25-Dihydroxyvitamin D3 Inhibits Esophageal Squamous Cell Carcinoma Progression by Reducing IL6 Signaling. Mol Cancer Ther 2015; 14:1365-75; PMID:25824337; https://doi.org/10.1158/1535-7163.MCT-14-0952
   PubMed Web of Science ®Google Scholar
• Muthian G, Raikwar HP, Rajasingh J, Bright JJ. One,25 Dihydroxyvitamin-D3 modulates JAK-STAT pathway in IL-12/IFNgamma axis leading to Th1 response in experimental allergic encephalomyelitis. J Neurosci Res 2006; 83:1299-309; PMID:16547967; https://doi.org/10.1002/jnr.20826
   PubMed Web of Science ®Google Scholar
• Wang Q, Li H, Xie H, Fu M, Guo B, Ding Y, Li W, Yu H. Twenty-five-Hydroxyvitamin D3 attenuates experimental periodontitis through downregulation of TLR4 and JAK1/STAT3 signaling in diabetic mice. J Steroid Biochem Mol Biol 2013; 135:43-50; PMID:23333931; https://doi.org/10.1016/j.jsbmb.2013.01.008
   PubMed Web of Science ®Google Scholar
• Teleni L, Baker J, Koczwara B, Kimlin MG, Walpole E, Tsai K, Isenring EA. Clinical outcomes of vitamin D deficiency and supplementation in cancer patients. Nutr Rev 2013; 71:611-21; PMID:24032365; https://doi.org/10.1111/nure.12047
   PubMed Web of Science ®Google Scholar
• Gocek E, Studzinski GP. The Potential of Vitamin D-Regulated Intracellular Signaling Pathways as Targets for Myeloid Leukemia Therapy. J Clin Med 2015; 4:504-34; PMID:26239344; https://doi.org/10.3390/jcm4040504
   PubMed Web of Science ®Google Scholar
• Christakos S, Dhawan P, Verstuyf A, Verlinden L, Carmeliet G. Vitamin D: Metabolism, Molecular Mechanism of Action, and Pleiotropic Effects. Physiol Rev 2016; 96:365-408; PMID:26681795; https://doi.org/10.1152/physrev.00014.2015
   PubMed Web of Science ®Google Scholar
• Vidal M, Ramana CV, Dusso AS. Stat1-vitamin D receptor interactions antagonize 1,25-dihydroxyvitamin D transcriptional activity and enhance stat1-mediated transcription. Mol Cell Biol 2002; 22:2777-87; PMID:11909970; https://doi.org/10.1128/MCB.22.8.2777-2787.2002
   PubMed Web of Science ®Google Scholar
• Lange CM, Gouttenoire J, Duong FH, Morikawa K, Heim MH, Moradpour D. Vitamin D receptor and Jak-STAT signaling crosstalk results in calcitriol-mediated increase of hepatocellular response to IFN-α. J Immunol 2014; 192:6037-44; PMID:24821973; https://doi.org/10.4049/jimmunol.1302296
   PubMed Web of Science ®Google Scholar
• Loughran TP, Jr., Zickl L, Olson TL, Wang V, Zhang D, Rajala HL, Hasanali Z, Bennett JM, Lazarus HM, Litzow MR, et al. Immunosuppressive therapy of LGL leukemia: prospective multicenter phase II study by the Eastern Cooperative Oncology Group (E5998). Leukemia 2015; 29:886-94; PMID:25306898; https://doi.org/10.1038/leu.2014.298
   PubMed Web of Science ®Google Scholar
• Veldman CM, Cantorna MT, DeLuca HF. Expression of 1,25-dihydroxyvitamin D(3) receptor in the immune system. Arch Biochem Biophys 2000; 374:334-8; PMID:10666315; https://doi.org/10.1006/abbi.1999.1605
   PubMed Web of Science ®Google Scholar
• Weeres MA, Robien K, Ahn YO, Neulen ML, Bergerson R, Miller JS, Verneris MR. The effects of 1,25-dihydroxyvitamin D3 on in vitro human NK cell development from hematopoietic stem cells. J Immunol 2014; 193:3456-62; PMID:25149465; https://doi.org/10.4049/jimmunol.1400698
   PubMed Web of Science ®Google Scholar
• Dawson MI, Xia Z. The retinoid X receptors and their ligands. Biochim Biophys Acta 2012; 1821:21-56; PMID:22020178; https://doi.org/10.1016/j.bbalip.2011.09.014
   PubMed Web of Science ®Google Scholar
• Larsen L, Ropke C. Suppressors of cytokine signalling: SOCS. APMIS 2002; 110:833-44; PMID:12645661; https://doi.org/10.1034/j.1600-0463.2002.1101201.x
   PubMed Web of Science ®Google Scholar
• Bohmer FD, Friedrich K. Protein tyrosine phosphatases as wardens of STAT signaling. JAKSTAT 2014; 3:e28087; PMID:24778927
   PubMedGoogle Scholar
• Sunn KL, Cock TA, Crofts LA, Eisman JA, Gardiner EM. Novel N-terminal variant of human VDR. Mol Endocrinol 2001; 15:1599-609; PMID:11518809; https://doi.org/10.1210/mend.15.9.0693
   PubMed Web of Science ®Google Scholar
• Gardiner EM, Esteban LM, Fong C, Allison SJ, Flanagan JL, Kouzmenko AP, Eisman JA. Vitamin D receptor B1 and exon 1d: functional and evolutionary analysis. J Steroid Biochem Mol Biol 2004; 89-90:233-8; PMID:15225777; https://doi.org/10.1016/j.jsbmb.2004.03.078
   Web of Science ®Google Scholar
• Ishaq M, Fan M, Wigmore K, Gaddam A, Natarajan V. Regulation of retinoid X receptor responsive element-dependent transcription in T lymphocytes by Ser/Thr phosphatases: functional divergence of protein kinase C (PKC)theta; and PKC α in mediating calcineurin-induced transactivation. J Immunol 2002; 169:732-8; PMID:12097375; https://doi.org/10.4049/jimmunol.169.2.732
   PubMed Web of Science ®Google Scholar
• Szabova L, Macejova D, Dvorcakova M, Mostbock S, Blazickova S, Zorad S, Walrand S, Cardinault N, Vasson MP, Rock E, et al. Expression of nuclear retinoic acid receptor in peripheral blood mononuclear cells (PBMC) of healthy subjects. Life Sci 2003; 72:831-6; PMID:12479981; https://doi.org/10.1016/S0024-3205(02)02307-X
   PubMed Web of Science ®Google Scholar
• Young HA, Hardy KJ. Interferon-gamma: producer cells, activation stimuli, and molecular genetic regulation. Pharmacol Ther 1990; 45:137-51; PMID:2105509; https://doi.org/10.1016/0163-7258(90)90012-Q
   PubMed Web of Science ®Google Scholar
• Rigby WF, Denome S, Fanger MW. Regulation of lymphokine production and human T lymphocyte activation by 1,25-dihydroxyvitamin D3. Specific inhibition at the level of messenger RNA. J Clin Invest 1987; 79:1659-64; PMID:2884234; https://doi.org/10.1172/JCI113004
   PubMed Web of Science ®Google Scholar
• Boissier MC, Assier E, Falgarone G, Bessis N. Shifting the imbalance from Th1/Th2 to Th17/treg: the changing rheumatoid arthritis paradigm. Joint Bone Spine 2008; 75:373-5; PMID:18571969; https://doi.org/10.1016/j.jbspin.2008.04.005
   PubMed Web of Science ®Google Scholar
• Alroy I, Towers TL, Freedman LP. Transcriptional repression of the interleukin-2 gene by vitamin D3: direct inhibition of NFATp/AP-1 complex formation by a nuclear hormone receptor. Mol Cell Biol 1995; 15:5789-99; PMID:7565732; https://doi.org/10.1128/MCB.15.10.5789
   PubMed Web of Science ®Google Scholar
• Cippitelli M, Santoni A. Vitamin D3: a transcriptional modulator of the interferon-gamma gene. Eur J Immunol 1998; 28:3017-30; PMID:9808170; https://doi.org/10.1002/(SICI)1521-4141(199810)28:10%3c3017::AID-IMMU3017%3e3.0.CO;2-6
   PubMed Web of Science ®Google Scholar
• Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. Cell 2010; 140:883-99; PMID:20303878; https://doi.org/10.1016/j.cell.2010.01.025
   PubMed Web of Science ®Google Scholar
• Stio M, Treves C, Celli A, Tarantino O, d'Albasio G, Bonanomi AG. Synergistic inhibitory effect of cyclosporin A and vitamin D derivatives on T-lymphocyte proliferation in active ulcerative colitis. Am J Gastroenterol 2002; 97:679-89; PMID:11922564; https://doi.org/10.1111/j.1572-0241.2002.05549.x
   PubMed Web of Science ®Google Scholar
• Gepner P, Amor B, Fournier C. One,25-dihydroxyvitamin D3 potentiates the in vitro inhibitory effects of cyclosporin A on T cells from rheumatoid arthritis patients. Arthritis Rheum 1989; 32:31-6; PMID:2521453; https://doi.org/10.1002/anr.1780320106
   PubMed Web of Science ®Google Scholar
• Lamy T, Liu JH, Landowski TH, Dalton WS, Loughran TP, Jr. Dysregulation of CD95/CD95 ligand-apoptotic pathway in CD3(+) large granular lymphocyte leukemia. Blood 1998; 92:4771-7; PMID:9845544
   PubMed Web of Science ®Google Scholar
• Doi K, Liu Q, Gowda K, Barth BM, Claxton D, Amin S, Loughran TP, Jr., Wang HG. Maritoclax induces apoptosis in acute myeloid leukemia cells with elevated Mcl-1 expression. Cancer Biol Ther 2014; 15:1077-86; PMID:24842334; https://doi.org/10.4161/cbt.29186
   PubMed Web of Science ®Google Scholar
• McGrath T, Latoud C, Arnold ST, Safa AR, Felsted RL, Center MS. Mechanisms of multidrug resistance in HL60 cells. Analysis of resistance associated membrane proteins and levels of mdr gene expression. Biochem Pharmacol 1989; 38:3611-9; PMID:2573357; https://doi.org/10.1016/0006-2952(89)90134-2
   PubMed Web of Science ®Google Scholar